Targeted diagnostic prostate biopsies: A state-of-the-art approach
If prostate cancer is suspected, a biopsy may be required. With the assistance of a high-resolution prostate scan, a more refined, targeted biopsy is performed. At Insite, we use Dynacad software to fuse MRI and ultrasound images together to target potential prostate cancers in real time. The result is a highly-accurate targeting system that demonstrates the precise location of a possible cancer so that doctors can see what was, only a few years ago, often invisible. Our doctors were some of the earliest adopters of this technology and, as such, have acquired a level of experience with it that is exceedingly rare.
Some men may have elevated serum PSA levels, but a biopsy has not revealed any cancerous cells. A prostate MRI may reveal the presence of a tumor that could not be confirmed with a biopsy. Research into prostate cancer indicates that an MRI-directed biopsy can detect prostate cancer in between 34 to 41 percent of men who have a prior negative biopsy.